KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Common Equity (2020 - 2025)

Historic Common Equity for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $906.0 million.

  • Organon's Common Equity rose 8377.28% to $906.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $906.0 million, marking a year-over-year increase of 8377.28%. This contributed to the annual value of $472.0 million for FY2024, which is 77428.57% up from last year.
  • Per Organon's latest filing, its Common Equity stood at $906.0 million for Q3 2025, which was up 8377.28% from $733.0 million recorded in Q2 2025.
  • Organon's Common Equity's 5-year high stood at $4.7 billion during Q1 2021, with a 5-year trough of -$1.9 billion in Q2 2021.
  • Over the past 5 years, Organon's median Common Equity value was -$555.0 million (recorded in 2023), while the average stood at -$173.5 million.
  • Per our database at Business Quant, Organon's Common Equity plummeted by 12748.82% in 2021 and then skyrocketed by 102916.67% in 2025.
  • Over the past 5 years, Organon's Common Equity (Quarter) stood at -$1.5 billion in 2021, then soared by 40.85% to -$892.0 million in 2022, then skyrocketed by 92.15% to -$70.0 million in 2023, then soared by 774.29% to $472.0 million in 2024, then skyrocketed by 91.95% to $906.0 million in 2025.
  • Its Common Equity was $906.0 million in Q3 2025, compared to $733.0 million in Q2 2025 and $542.0 million in Q1 2025.